drugset / Trial / NCT00349401

Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation

NCT00349401

RandomizedDouble-blindTreatment

Summary

The purpose of this study is to determine how the drug ketorolac, when given with the spinal morphine, affects pain.

Timeline

Start
2006-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified Intrathecal
Background Morphine Other / unclassified Intrathecal

Indications

No indication recorded.